Our finding that CARM1 overexpression in breast cancer correlated with high HER2 expression supports the hypothesis that CARM1 might play an important role in the regulation of the HER2 pathway, probably through transcriptional coactivation with the p160 family. This evidence concerns the gene ERBB2 and breast cancer.